Cargando…
Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions
There are no current treatments for autism, despite its high prevalence. Deletions of chromosome 16p11.2 dramatically increase risk for autism, suggesting that mice with an equivalent genetic rearrangement may offer a valuable model for the testing of novel classes of therapeutic drug. 16p11.2 delet...
Autores principales: | Mitchell, Emma J., Thomson, David M., Openshaw, Rebecca L., Bristow, Greg C., Dawson, Neil, Pratt, Judith A., Morris, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378168/ https://www.ncbi.nlm.nih.gov/pubmed/32704009 http://dx.doi.org/10.1038/s41598-020-69130-8 |
Ejemplares similares
-
16p11.2 deletion mice exhibit compromised fronto-temporal connectivity, GABAergic dysfunction, and enhanced attentional ability
por: Openshaw, Rebecca L., et al.
Publicado: (2023) -
F41. SCHIZOPHRENIA-RELEVANT ALTERATIONS IN CEREBRAL METABOLISM, GLUTAMATE AND MONOAMINERGIC NEUROTRANSMITTER SYSTEM FUNCTION IN A MOUSE MODEL OF 16P11.2 DUPLICATION
por: Bristow, Greg, et al.
Publicado: (2018) -
Sensory processing in 16p11.2 deletion and 16p11.2 duplication
por: Smith, Harriet, et al.
Publicado: (2022) -
Psychiatric disorders in children with 16p11.2 deletion and duplication
por: Niarchou, Maria, et al.
Publicado: (2019) -
Pervasive genetic interactions modulate neurodevelopmental defects of the autism-associated 16p11.2 deletion in Drosophila melanogaster
por: Iyer, Janani, et al.
Publicado: (2018)